Kyntra Bio
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $3,738 | $1,278 | $1,076 | $1,348 |
Gross Profit | -368 | 999 | 942 | 1,042 |
EBITDA | -13,818 | -9,299 | -10,871 | -11,545 |
EBIT | -9,307 | -11,063 | -11,766 | |
Net Income | -15,198 | -14,220 | 148,473 | -7,603 |
Net Change In Cash | 3,738 | 1,278 | 1,076 | 1,348 |
Free Cash Flow | -13,887 | -18,328 | -1,856 | 12,669 |
Cash | 36,997 | 47,872 | 117,975 | 23,367 |
Basic Shares | 4,047 | 4,046 | 4,044 | 4,042 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $6,440 | $29,621 | $46,803 | $140,734 |
Gross Profit | 5,884 | 14,060 | 42,841 | 120,454 |
EBITDA | -45,895 | -142,428 | -305,197 | -282,825 |
EBIT | -46,643 | -145,120 | -315,127 | -293,429 |
Net Income | 183,452 | -47,579 | -284,232 | -293,654 |
Net Change In Cash | 6,440 | 29,621 | 46,803 | 140,734 |
Free Cash Flow | -4,812 | -138,265 | -317,540 | -184,674 |
Cash | 47,872 | 50,482 | 113,688 | 155,700 |
Basic Shares | 4,043 | 100,044 | 97,303 | 93,582 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$3.76 |
2025-12-31 | -$3.51 |
2025-09-30 | $49.61 |
2025-06-30 | -$1.88 |